phne no


If we confess our sins, he is faithful and just and will forgive us our sins and purify us from all unrighteousness.

23 Nov 2017


Hi Friends,   The Future of Biotechnology:   The biotechnology  sector of India is highly innovative and is on a strong growth trajectory.  The sector, with its immense growth potential, will continue to play a significant role as an innovative manufacturing hub.  The sector is one of the most significant sectors in enhancing India’s global profile as well as contributing to the growth of the economy.  India is among the top 12 biotech destinations in the world and ranks third in the Asia-Pacific region.  India has the second-highest number of US Food and Drug Administration (USFDA) approved plants, after the USA and is the largest producer of recombinant Hepatitis B vaccine.  Out of the top 10 biotech companies in India (by revenue), seven have expertise in bio-pharmaceuticals and three specialise in agri-biotech.

Market Size:  The Indian biotech industry holds about 2 per cent share of the global biotech industry.  The biotechnology industry in India, comprising about 800 companies, is growing at an average rate of about 20 per cent.  The Indian biotechnology sector is expected to grow from the current  US$ 5-7 billion to US$ 100 billion by 2025, growing at an average rate of 30 per cent, as per Union Minister for Science and Technology  Mr. Harsh Vardhan.  Biopharma is the largest sector contributing about 64 per cent of the total revenue followed by bioservices  (18 per cent ) , bio-agri (14 percent) bio industry (3 per cent), and bioinformatics contributing ( 1 per cent).  The high demand for different biotech products has also opened up scope for the foreign companies to set up base in India. India has emerged as a leading destination for clinical trials, contract research and manufacturing activities owing to the growth in the bio services sector.

Road Ahead:  The Govt. of India has allocated Rs.7,288 crore (US$ 1.09 billion) in the Union Budget 2015 – 16 for conducting research , after  an increase of Rs.1,793 crore (US$ 269.70 million) compared to the Budget of 2014-15.  With the country offering numerous comparative advantages in terms of R & D facilities, knowledge, skills, and cost effectiveness, the  biotechnology industry  in India has immense potential to emerge as a global key player.  India constitutes around 8 per cent of the total  global generics market, by volume, indicating a huge untapped opportunity in the sector.  Outsourcing to India is projected to spike up after the discovery and manufacture of formulations.  Hybrid seeds, including GM seeds, represent new business opportunities in India based on yield improvement.  India currently has a marginal share in the global market for industrial enzymes that is estimated to reach about US$ 4.4 billion by 2015.  Hence, there is an opportunity in focussed R&D  and knowledge based  innovation in the field of industrial enzymes, which can innovatively replace polluting chemical processes into eco-friendly processes that also deliver environmental sustainability.  Another interesting field of study is the area of bio-markers and companion diagnostics,  which will enable to optimise the benefits of biotech drugs.  India has all the ingredients to become a global leader in affordable healthcare.  If there is an annual investment of   US$ 4.01 billion to US$ 5.02 billion in the next five years, the biotech industry can grow  to  US 100 billion by 2025, with a 25 per cent return on investment, and set a growth rate of 30 per cent year – on – year.

Good Luck.                                                                         See You Later.

No comments:

Post a Comment